Taking a look at some of the American Gastroenterological association guidelines from the past 6 months that covers Fecal Microbiota Transplantation, IBD biomarkers and dietary recommendations, and a few more updates in ascites and cirrhosis management via albumin and vasoactive medications.

| 00.00 - Intro

| 00.52 - FMT [AGA 2024] |

| 03.31 - The use of Biomarkers in Crohn’s Disease [Gastro 2023] + a quick call do Dr. Sara Lewin, inpatient IBD specialist at UCSF |

| 10.42 - IBD dietary recommendations [AGA 2024] + a chat with RD Neha Shah, IBD dietary specialist at UCSF |

| 22.26 - Albumin, vasoactives, and ascites [AGA 2022] |

| 24.24 - Summary |

[The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the information, products, or services contained therein. UCSF does not exercise any editorial control over the information found therein, nor does UCSF make any representation of their accuracy or completeness. All information contained in this episode are the opinions of the respective speakers and not necessarily the views their respective institutions or UCSF, and is only provided for information purposes, not to diagnose or treat.]

Music by Amit Apte. Image generated using Copilot.